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Strengths and limitations of this study
 ► The study was designed with the help of a group of 
patients with chronic pelvic pain.
 ► Patient recruitment to the study was good.
 ► Our study focused on a deprived urban area in the 
UK and considered typical local clinical patients, 
which is not commonly done.
 ► The qualitative evaluation included the perspectives 
of both the patients and a variety of healthcare staff.
 ► Patients in the qualitative evaluation preferred tele-
phone interviews over the offered face- to- face focus 
groups.
AbStrACt
Objectives To determine whether a pre- existing 
smartphone app to teach mindfulness meditation is 
acceptable to women with chronic pelvic pain (CPP) and 
can be integrated into clinical practice within the National 
Health Service (NHS) CPP pathways, and to inform the 
design of a potential randomised clinical trial.
Design A prestudy patient and public involvement (PPI) 
group to collect feedback on the acceptability of the 
existing app and study design was followed by a three- 
arm randomised feasibility trial. In addition, we undertook 
interviews and focus groups with patients and staff to 
explore app usability and acceptability. We also obtained 
participant comments on the research process, such as 
acceptability of the study questionnaires.
Setting Two gynaecology clinics within Barts Health NHS, 
London, UK.
Participants Patients with CPP lasting ≥6 months 
with access to smartphone or personal computer and 
understanding of basic English.
Intervention The intervention was mindfulness 
meditation content plus additional pain module delivered 
by a smartphone app. Active controls received muscle 
relaxation content from the same app. Passive (waiting list) 
controls received usual care.
Main outcome measures Themes on user feedback, app 
usability and integration, and reasons for using/not using 
the app.
results The use of the app was low in both active 
groups. Patients in the prestudy PPI group, all volunteers, 
were enthusiastic about the app (convenience, content, 
portability, flexibility, ease of use). Women contributing 
to the interview or focus group data (n=14), from a ‘real 
world’ clinic (some not regular app users), were less 
positive, citing as barriers lack of opportunities/motivation 
to use the app and lack of familiarity and capabilities with 
technology. Staff (n=7) were concerned about the potential 
need for extra support for them and for the patients, and 
considered the app needed organisational backing and 
peer acceptance.
Conclusion The opinions of prestudy PPI volunteers 
meeting in their private time may not represent those of 
patients recruited at a routine clinic appointment. It may be 
more successful to codesign/codevelop an app with typical 
users than to adapt existing apps for use in real- world 
clinical populations.
trial registration number ISRCTN10925965.
IntrODuCtIOn
Smartphone health apps, as one form of 
mobile health (mHealth),1 are popular in the 
UK, which is our study setting. With more than 
two- thirds of the UK population using smart-
phones,2–4 health apps are one of the fastest 
growing app categories, and the number of 
users is still increasing.5 Currently these apps 
are usually developed either by researchers 
or (in the majority) by commercial compa-
nies, without collaboration between these 
groups.6 7 The lack of interaction between 
researchers and commercial developers in 
the field of pain- related apps has led to a situ-
ation where commercially available apps have 
not been scientifically validated and apps that 
have been developed from research projects 
are not commercially available.8
We were interested in using an app to 
support women with chronic pelvic pain 
(CPP) in a clinical setting, where validation 
School of M









pen: first published as 10.1136/bmjopen-2019-030711 on 12 March 2020. Downloaded from 
2 Ball E, et al. BMJ Open 2020;10:e030711. doi:10.1136/bmjopen-2019-030711
Open access 
of an intervention is important to ensure best care. CPP is 
defined as a subjective physical and emotional experience 
of pain in the pelvic area that has been present for at least 
6 months and which may or may not have an identifiable 
pathology.9 CPP affects up to 24% of women worldwide10 
and accounts for 20% of gynaecological clinic refer-
rals.11 12 It has considerable impact on patients’ quality of 
life, including their mental health and income13 due to 
loss of working days and diminished work capacity. The 
annual cost to the National Health Service (NHS) has 
been estimated at approximately £326 million.14 For endo-
metriosis alone, which is only one cause of CPP, a Euro-
pean study of over 900 women showed an average annual 
total cost per woman of €9579. The cost of productivity 
loss of €6298 was double the healthcare cost of €3113 
per woman. The latter was due to surgery (29%), moni-
toring tests (19%), hospitalisation (18%) and physician 
visits (16%).15
Despite costly interventions, CPP is often resistant to 
surgical and medical treatment and appears to respond 
better to a multimodal, holistic approach,16 with a focus 
on coping strategies. A systematic review of randomised 
controlled trials (RCTs) has identified mindfulness medi-
tation (MM) as an effective coping strategy in other 
chronic pain conditions.17 In addition, evidence from 
uncontrolled trials suggests positive effects of MM on CPP, 
such as an increased ability to control pain, and improve-
ments in mental health, emotional well- being, work, and 
family life and social functioning.18 19 These however have 
never been examined in an RCT.
We therefore chose to evaluate MM delivered via an app 
to women with CPP as our intervention. CPP is especially 
common in younger women, who may be categorised as 
digital natives, making an app- based intervention particu-
larly appropriate to this group.
In MM the aim is to stay focused on one’s own breathing. 
Whenever attention wanders to intrusive thoughts and 
feelings, these are simply taken notice of in a neutral 
way, that is, without elaboration or judgements or consid-
eration of action. They are then let go as attention is 
returned to breathing. The idea is to bring awareness 
back to the here and now whenever worries and troubles 
intrude into thoughts.20
Generally two main complementary approaches have 
been used for MM: (1) exercises focusing one’s attention 
to the present moment and (2) monitoring of experi-
ences in the present moment. While systematic reviews 
show that MM may have positive effects on depression, 
quality of life and pain symptoms in patients with chronic 
pain,17 21 22 and that apps with an MM focus have been 
shown to be beneficial for various chronic conditions,23 
none of the reviewed papers included meditation deliv-
ered via mobile phone apps or in women with CPP.
Evaluation of an existing app is considered to often 
be appropriate24 and is both quicker and more cost- 
effective than designing an app from scratch. We chose 
to evaluate an existing commercial app platform that 
teaches mindfulness by guided meditation, with a 10- day 
basic meditation module followed by a pain module 
specifically designed for the MEMPHIS (Mindfulness 
meditation using a smartphone application for women 
with chronic pelvic pain) study. The Headspace app we 
used was publicly nominated the favourite health app of 
2013,25 has a five- star user rating in the Apple app store, 
and has scored top in a systematic review of 23 mind-
fulness apps using the Mobile Application Rating Scale 
(visual aesthetics, engagement, functionality or infor-
mation quality).26 Headspace had reportedly seen over 
15 million downloads up to mid-2018, when our study 
began.27 To our knowledge the Headspace app in its orig-
inal or modified form had not been assessed in any other 
pain conditions.
We undertook a three- arm, parallel, randomised feasi-
bility trial (MEMPHIS)28 to assess whether or not to 
proceed with a full RCT of the modified Headspace medi-
tation app for women with CPP. In the current paper we 
report on the qualitative interview and focus group data 
from this study; the protocol and quantitative results have 
been published/submitted.29 30 Our aim for the qualita-
tive part of this study was to determine whether a pre- 
existing smartphone app to teach MM is acceptable to 
women with CPP and can be integrated into clinical prac-
tice within the NHS CPP pathways. The objectives were 
to consider:
 ► Acceptability, use and usability of the app in the 
intended service user population and for healthcare 
professionals (doctors, healthcare assistants, clinic 
and research nurses).
 ► Feasibility of integrating such an app into existing 
healthcare pathways.
 ► Usefulness of having a distinct patient group to advise 
us on the study design.
MethODS
Outcomes
The outcomes of this analysis were inductively derived 
descriptive themes on acceptability, use and usability 
of the app, and feasibility of integrating the app into 
existing pathways. We follow the ISO 9241-11 (Interna-
tional Organization for Standardization; https://www. iso. 
org/ obp/ ui/# iso: std: iso: 9241:−11:ed-2:v1:en) concept of 
technology usability (user- friendliness) as the extent to 
which the app could be satisfactorily used by participants 
to meditate. By acceptability we mean whether partici-
pants could see a reason for using the app when given 
in the clinic and would be happy to use it for meditation.
Intervention procedures
Women in the MM group received access to a 60- day 
progressive MM course delivered via the Headspace 
app. The first 10 days of the course taught the basics of 
MM. Following this, participants were able to access the 
module on meditation which was targeted for chronic 
pain. This module had been specifically made for this 
study. The length of the session was 10 min for the first 
10 days, 15 min up to day 20, and 20 min up to day 60. 
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The active control group received access to a series of 
muscle relaxation sessions. These sessions were identical 
every day, except that their duration increased to mirror 
the increasing duration of the meditation content being 
listened to by the intervention group. Usage data are 
reported elsewhere.30
Patient and public involvement
We held a patient and public involvement (PPI) group 
workshop before the study to discuss the acceptability 
of the Headspace app and to help us design our study. 
Women attending the Royal London Hospital CPP clinic 
were invited to volunteer for a week of using the unmod-
ified (normal commercially available) Headspace app 
(which did not have the pain module at the time we 
undertook our prestudy workshop) and then feed back 
on their experiences with the app in an evening discus-
sion group. Women were not involved in the design of 
the modified app. The focus of the PPI group was on the 
use of the generic MM app. However, two patient repre-
sentatives provided support from the study design stage 
through to recruitment, and to the interpretation of the 
results, and regularly attended trial management group 
meetings.
Study recruitment and eligibility
The trial recruited patients from two outpatient gynae-
cology clinics within the Barts Health NHS Trust in two 
separate deprived areas of inner East London. Female 
patients with new or follow- up gynaecology appointments 
were assessed for eligibility by a researcher in the clinic, 
having been posted a patient information sheet. Women 
were eligible if they had been suffering from CPP for 6 
months or more and had at least a basic understanding of 
the English language, sufficient to follow instructions, as 
assessed during discussion about the study for informed 
consent; in the event, no women were excluded on this 
basis. Women were excluded if they did not meet these 
criteria or they did not have access to a smartphone or 
personal computer, or were currently using the Head-
space app (there were very few of the latter, according to 
the impression of the recruiting nurses). All patients gave 
full and informed consent to be randomised. All health-
care professionals and research nurses involved in the two 
clinics (the only eligibility criterion applied for staff) were 
also invited to take part in the feasibility study. Full enrol-
ment data are provided in Forbes et al.30 A key difference 
from women in the PPI group was that the focus of the 
feasibility study patients was on managing their pain, with 
the app given explicitly as part of their clinic manage-
ment support.
For the analysis of quantitative data, 90 patients were 
allocated randomly in a 1:1:1 ratio to the MM app, a 
muscle relaxation app active control or the usual care 
arm (for full details, see Ball et al.).29 Patients in the two 
active arms were asked to download the modified app in 
the clinic with support from a research staff member and 
were sent a questionnaire about app usability, an analysis 
of which is reported in a companion paper.30 We used 
data from the app usability questionnaire to inform topic 
guides for the qualitative part of the study. This uncov-
ered and outlined key usability issues to guide our semi-
structured interviews and focus groups with patients and 
staff.
All women in the intervention and active control arms 
were eligible for the qualitative component of the study, 
as well as all staff participating in the study.
Within-study interviews and focus groups
All patients in the intervention and active control arms 
were invited to one of the two focus groups at their own 
study site after the 6- month follow- up. We offered tele-
phone interviews as an alternative. Patients were asked to 
‘walk through’ the app with researchers, articulating their 
thought processes while they did so and commenting on 
its different specific features.31 Walkthroughs are often 
used in developing technologies such as mHealth. This 
helped to identify app usability issues or barriers to use 
of the app from users’ points of view without the need 
for technical discussions. The results of the walkthrough, 
with comments on the different features specific to 
the usability of the intervention app used in our study, 
are shown in online supplementary appendix 1; walk-
throughs were undertaken by two patients. Patients also 
discussed with us their experiences around app usability 
and acceptability.
Staff were invited to attend a staff focus group over-
seen by the patient representative and facilitated by a 
researcher. Consultants, healthcare assistants, clinic and 
research nurses, and representatives from the Pelvic Pain 
Support Network were eligible. In addition to consid-
ering app usability and acceptability, members of the staff 
focus group were asked about the ease of integration into 
existing NHS pathways. Part of the staff discussion was free- 
flowing with open- ended questions, which gave us patient- 
focused information on app acceptability, and part was 
structured using questions developed from the Normalisa-
tion Process Theory (NPT) toolkit as recommended by its 
developers.32 For example, we asked whether staff could 
see a purpose for the app in clinical practice, as adding 
something different, which corresponds to the NPT 
toolkit question ‘Participants distinguish the intervention 
from current ways of working’. Since we used a semistruc-
tured approach, questions were not rigidly worded. This 
helped us to consider the feasibility of integration of the 
app into practice. NPT is a theory of implementation prac-
tices that was initially developed for consideration of tech-
nology implementation and is commonly used.32
All data were audio- recorded at point of collection and 
were transcribed, with personal identifying data removed 
from the transcripts. Raw data were stored in a Primary 
Care Clinical Trial Unit database adhering to clinical trial 
standards.
Analysis
Analysis of within- study focus groups and interviews 
was carried out blinded as to which study app was used 
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and deployed the immersion- crystallisation method.33 
Thus, the lead qualitative researcher immersed herself 
in the data, reading transcripts carefully, then writing 
down articulated or crystallised patterns or themes that 
related to the study’s aims and research questions. These 
were discussed with another researcher from the team, 
and themes were modified as appropriate. This process 
was repeated until all the data had been examined and 
all patterns that had been observed were articulated, 
discussed and substantiated with exemplar extracts. This 
approach was considered appropriate since we had a 
small data set and we were not aiming to develop concep-
tual themes but rather to inform the design and develop-
ment of an RCT for the modified app.
We used the Standards for Reporting Qualitative 
Research checklist when writing our report.34
reSultS
We screened 488 women between May and September 
2016 for eligibility to participate in the study. After exclu-
sions, 90 women gave full consent to participate and were 
randomised to the intervention arm (31 women), active 
control arm (30 women) or usual care arm (29 women).
Demographics
Women in the main feasibility trial30 had a mean age of 
35 years, 66% were employed, and overall approximately 
50% had stayed in full- time education until at least the age 
of 20, although the proportion was lowest in the interven-
tion arm at 36.7%. Overall 44% were of white ethnicity, 
although the proportion was lowest in the intervention 
arm (35.7%) and highest in the usual care arm (53.6%). 
The second most common self- reported ethnic groups 
were ‘Southern Asian’ and ‘Black’. Women in the inter-
vention arm were most likely to have experienced CPP for 
3–5 years (40.3% of this group) and women in the usual 
care group for over 10 years (42.9% of this group). More 
women had pain for longer than 2 years in the interven-
tion arm than in either of the other two arms. All women 
reported high pain intensity, with a mean of 6.8–6.9 in 
the previous week (on a scale from 1 to 10).30 These and 
other demographic data are reported in more detail in 
Forbes et al.30 Our qualitative sample was taken from the 
two active arms and comprised 16% of trial participants 
and 23% of those eligible for the qualitative study. We did 
not record separate demographic data for the women in 
this smaller sample.
Prestudy PPI group
The 10 women in the prestudy PPI group were self- 
selected local women who were familiar with using apps 
and focused on app use per se. They anticipated no tech-
nical issues for women in the trial, even those who were 
not used to apps. They considered that the Headspace 
app would be successfully adopted by patients taking 
part in the study, given that a smartphone, like CPP, is 
‘always with you’. They praised the flexibility of the app, 
welcomed its portability and were unanimous in saying 
it was easy to slip off for 10 min when at work to use it. 
As a result, they found they could use it at times when 
they most needed pain relief as well as to prevent pain, 
and found the app helpful in relieving pain and stress. 
The group reported being able to meditate without the 
app, once they had tried it with the app; however, they 
still preferred to use the app because they found the voice 
soothing.
App usage in the study
Patient usage of the app was less than expected from our 
prestudy PPI group discussions. Only 36% of meditation 
app patients and 46% of the active control patients used 
the app at least once.30
thematic analysis of within-study data
Qualitative data were obtained from 14 study patients; 
12 preferred a telephone interview and 2 attended face- 
to- face interviews, with 1 participant at the university 
attached to one of the recruiting clinics and the other 
participant at the other recruiting hospital. Patients chose 
not to attend focus groups. Four of the patients were from 
the active control arm and 10 from the intervention arm. 
The two women we met face to face had both used the 
intervention and neither had progressed beyond the 
training stage, something that we cannot discount for 
other participants and which may help to explain reports 
of lack of effect on pain. Seven people attended the staff 
focus group: two recruiting nurses, three clinic nurses, 
one consultant and a representative from the Pelvic Pain 
Support Network.
The qualitative analysis revealed three main themes and 
four subthemes with regard to usability from all within- 
study interviews and focus groups combined:
 ► Familiarity and capabilities with app technology.
 ► Motivations to use the app.
 – Perceived benefits.
 – Relation to other therapies.
 ► Opportunities to use the app.
 – Technology issues getting in the way.
 – Life getting in the way.
These are explored in the following sections. As the 
PPI group data were not research data, we did not analyse 
them for themes.
While we initially combined active control and interven-
tion groups in our analysis, we then looked for instances 
where there was a difference between these two groups. 
Only where we found this difference in any theme or state-
ment have we specified which group women belonged to.
Familiarity and capabilities with app technology
Around half of the patients were sufficiently familiar with 
technology and apps to be comfortable using the study 
apps. However, six participants (all using the interven-
tion, which was more complex than the active control) 
reported difficulty because they were “not very good at 
School of M
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technology” (Patient 1002, intervention), or were unsure 
how to get started or use the app effectively without help.
I am not good with technical some things that is why 
the problems I had arisen, right okay. So I consulted 
with my daughter and she helped me work it out…
so I don’t try everything. (Patient 1002, intervention)
One further patient (Patient 1001, intervention) was 
not used to technical app language; ‘help’ suggested 
emotional support to her, for example. Two more (one 
intervention, one active control) changed handsets and 
therefore did not continue with the app. In all cases these 
technical difficulties appeared to lead to abandoning of 
the app or to restricted use of its functionality.
Five patients having technical problems suggested 
possible solutions such as a ‘class’ or group for first- 
time users, a YouTube orientation video or a pictorial 
leaflet. This might include an introduction to meditation 
and mindfulness as well as the app itself. One woman 
commented: “If your market is targeting people who are 
not using apps then you are going to have to get together 
and find ways to do this” (Patient 1041, intervention); she 
also suggested we could get ideas from other apps on the 
market in this regard.
Given their experiences in the study, staff were 
concerned about the additional staff time needed to 
support women in using the app. This would sit in tension 
with one of the original rationales behind choosing an 
app as the mode of delivery, which was to increase the 
effective use of staff contact time with patients. Language 
barriers might compound problems.
Motivations to use the app
Staff, although unaware of the low sustained app use in 
the study, felt it would be common sense to hold occa-
sional motivating meetings with patients if the intention 
was for them to use the app long term. The patient data 
suggested the main motivators or lack of motivation for 
using the app in our sample, which could be drawn on in 
such meetings, and which we now consider.
Perceived benefits
Three patients from the intervention arm said they 
only entered the trial to help others through research, 
as were already using alternative forms of pain control. 
They explained that this meant they were not motivated 
to actually use the app, perceiving the relative benefit to 
be small. The failure of such altruism to extend to using 
the app is a recognised phenomenon in clinical trials and 
has been called ‘weak altruism’.35 Thus, only one of these 
three patients persevered. Even though she was one of the 
women who experienced difficulties with the technology, 
she explained: “with something that is as soul destroying 
as the pain, it is important to help others off the back of 
other people’s misfortune as it were” (Patient 1036, inter-
vention). However, she wondered how relevant her data 
were.
I took steps to improve my situation from a weight 
loss perspective as well and I’ve lost a lot of weight 
which has significantly helped not 100% but it is has 
significantly helped so I felt a bit fraudulent the last 
time filling in the forms because, so everything had 
improved so much so from the medical study per-
spective it was more about the weight loss than the 
app. So I felt a bit bad that I was still taking part. 
(Patient 1036)
There was no clear pattern regarding the impact of 
current pain on app use by patients. Six said they used 
it regardless of pain intensity—sometimes developing 
a daily routine—while four only used it when in severe 
pain or expecting to be (eg, during menstruation). This 
cyclical or intermittent use in some patients, which was 
irrespective of study arm, should be considered when 
looking at our main study outcomes.30 The Headspace 
app requires regular use to learn and benefit from psycho-
logical techniques. To address this, healthcare profes-
sional alerts have been effective in other studies,36 while 
Headspace only has a reminder function that the user can 
set. This feature was easily overlooked though it could be 
effective; as one patient said: “To be quite honest I used 
it [the app] a couple of times and then forgot. And then 
I [remembered the reminder function and] used it more 
frequently” (Patient 1036, intervention).
One patient said medication was not working but the 
app did, although she was not sure whether this was 
“mind over matter” (Patient 1065, intervention), which 
was her term for a placebo effect. Three others said it did 
not reduce their pain; all three were using the interven-
tion app. The remaining patients considered other bene-
fits were good reason for using the app even when they 
did not feel that it reduced pain intensity. Alternative or 
unanticipated benefits were not formally measured or 
taken into account in the study’s effectiveness outcomes.30 
For example, 10 patients valued the way the app helped 
them to relax or destress or to focus and reassess their 
life; three of these patients specifically said they used it to 
induce a relaxed state to get to sleep. Notably the active 
control was a relaxation app; however, this benefit was also 
reported by many women in the intervention arm. One 
participant (active control) said she did not like the focus 
on pain per se as her condition impacted on various areas 
of her life. Even when the intervention app was positively 
received, women might stop using it because it was too 
powerful, and they had gained the change they wanted:
I think it was day 3, I could see the change that was 
happening, I was able to speak up for myself…I can’t 
explain it, even now I am getting emotional…it’s 
just a lack of focus, I just needed direction. To try 
and put it into words. To me it meant so much that I 
have gone back to church…I use it outside of the app 
now I have got from it what was missing, so it’s done 
something to me and for me which is very positive, 
and I may try it to lose weight but those positive vibes 
are still there. I can’t go back to it because I did not 
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want to go any further because what I got at the time 
helped me to focus, to change my way of thinking. I 
used it for about two or three weeks. (Patient 1001, 
intervention)
Three patients from the intervention arm found the 
app put them more in tune with their bodies and their 
breathing (two of these were among those who also 
found the app destressing), while another found yoga 
better for that. Six patients, like the prestudy PPI group 
members, also learnt to use techniques from the app to 
alter their stress patterns without the app, having tried it 
for example in traffic or by sitting down and taking time 
out or for general relaxation. Again, this would impact on 
trial results.
Relation to other therapies
Two patients (both active control) preferred ‘pure’ medi-
tation, while another considered the app to be “very much 
about meditation” (Patient 1041, intervention), which 
is in keeping with the arms they were in. An alternative 
therapy practitioner and two further patients reported 
that they preferred yoga. One (active control) said this 
was because it focused on each part of the body in turn.
Three patients from the intervention arm thought the 
app was useful as an adjunct to other methods rather than 
a replacement, for example physical interventions such as 
Pilates or listening to classical music.
Opportunities to use the app
Technology issues getting in the way
Staff pointed out that not all patients had smartphones 
(not appreciating that personal computers/tablets were 
alternatives allowed in this study). Some patients lacked 
the storage space to load the app on their phones. There 
were also issues with Wi- Fi connectivity when the staff 
tried to help the patients load the app within the hospital 
sites. Possible solutions that the staff suggested were to 
lend patients phones and to have group upload sessions 
in a location with a good Wi- Fi signal, although they 
acknowledged the resource implications.
Life getting in the way
Seven patients revealed they preferred to use the app in 
the evenings due to other life commitments. This meant 
they did not always use it as a direct response to pain, 
reducing its potential for contemporaneous effect. One 
patient who used it in response to pain but only used it 
once or twice blamed this on having no spare time due 
to juggling work and children (active control). However, 
another patient (intervention) managed despite such 
commitments; the fact that she was in the intervention 
arm may have played a role.
barriers to integration for staff
Staff believed that the biggest barrier to clinical adoption 
of the app was a possible lack of support from the host 
organisation. It might also be hard to integrate the app 
within existing professional work practices if the staff in 
the position of offering the app to patients failed to see 
its relative advantage over other interventions. Collection 
of feedback on the app’s effectiveness would be neces-
sary for staff to support sustained use. It was felt that the 
staff would need training on how to introduce the app 
to women in practice, and that complexity and high staff 
turnover could impede sustained use. An app was also 
seen as impersonal compared with face- to- face contact, 
which was more favoured by the staff.
Participant comments on the research process
The study questionnaires that were used for the main 
quantitative outcome measures30 were acceptable to 
patients except for some discomfort with a question about 
sex, which the patients considered a delicate question 
that was missing a ‘no sex’ option. Most preferred a paper 
form, reflecting their lack of affinity with technology. 
There were no indications that the study design or the 
study processes had contributed to participants’ lack of 
engagement with the apps, with a caveat around support 
with the technology as mentioned above, although we did 
not systematically consider this. A full summary of patient 
comments on the study design and procedures is given in 
online supplementary appendix 1.
DISCuSSIOn
Our study adds to the limited evidence on mHealth app 
user behaviour and experience.36 37 The prestudy PPI 
group (young women, of a generation familiar with using 
apps and who were asked to focus on the study design use 
of the app) liked the idea of delivering the intervention 
via an app, praising the contemporary design and flexi-
bility. Hence we expected a similar positive attitude from 
trial participants, who were of a comparable age and we 
assumed would be keen on using apps. Participant feed-
back revealed that this assumption was too simplistic.
Using our qualitative data, we were able to explore the 
reasons for low app usage that had been recorded in our 
feasibility study.30 Our thematic analysis suggests that the 
low app use in the trial was because many patients were 
not familiar with apps in general or lacked capabilities 
with technology. This was particularly true for the more 
complex intervention app. The other themes we report 
did not differ between groups (although the three cases 
of ‘weak altruism’ all occurred in the intervention arm), 
which suggests more generic issues that can be transfer-
able to other app use situations. For example, women 
stated limited motivation to use the app because of a lack 
of perceived benefit, or a lack of opportunity to use the 
app due to Wi- Fi issues or due to other commitments.
Similar findings were reported by Laurie and Bland-
ford,38 who interviewed 16 healthy city- dwelling partici-
pants (25–38 years) about their behaviour before and 
after 30–40 days of Headspace app exposure. Similar to 
our study, they reported barriers such as busy lives, failure 
to establish a routine and a lack of perceived benefit; all 
users in their study tried the app at least once hoping it 
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could deliver a quick fix but were disappointed if this did 
not happen. In our study many patients failed to perceive 
a benefit from using the app. Hence excuses stating other 
commitments may mask a deeper lack of motivation 
linked to perceptions of benefits.39
The advantages and disadvantages of using the app 
as a stand- alone were also illustrated by our data. Some 
suggestions made by participants to improve usage, such 
as more guidance at the start, seem obvious in hindsight. 
But they had not been considered because of the feed-
back from the prestudy PPI group and the commercial 
success of Headspace. The use of community contacts 
may be a helpful alternative.40 Social support can create 
a community of practice, help to clarify expectations41 
and improve health outcomes (as shown, for example, in 
internet- based psychological treatment for depression).42
The data suggest that for successful app use we need 
to understand what motivates individuals with clinical 
need to use the app for clinical reasons (which our PPI 
group did not focus on) and target this, for example by 
setting appropriate expectations. Incentivisation might 
also improve motivation. This could be achieved through 
app gamification,7 or encouragement through integra-
tion with patient–clinician face- to- face encounters, which 
was lacking in our study since the app was used as a 
stand- alone. The present study provided extensive initial 
technical support but no coaching and incentivising, in 
keeping with the protocol. Future app studies should take 
this into account. Participants in our study may also have 
benefited from training and support to improve their 
app use capabilities and guidance on how to create more 
opportunities for app use, such as through sharing expe-
riences in clinic support groups. This is in keeping with 
the COM- B model of behaviour change,43 which matched 
our themes, although this was only realised after the anal-
ysis. The COM- B model states that capability, opportunity 
and motivation are key drivers of behaviours. This has 
been used to develop a number of complex interventions 
including smartphone apps.3
Lack of engagement after recruitment, or good initial 
engagement but minimal or inconsistent use, has been 
reported in other studies.44–47 This includes two Head-
space trials other than our own,46 47 set in a university and 
a psychiatric inpatient clinic, and both in the USA. Incon-
sistent app use was noted by Wen et al48 among junior 
doctors who used self- guided Headspace. Morrison Wylde 
et al49 compared face- to- face MM with Headspace use in 
novice paediatric nurses. However, unlike our study, there 
were no recorded dropouts/non- users and also no record 
of whether or how long the app was used, which is an 
important omission.
None of these studies included a qualitative compo-
nent. Yet each of the Headspace study groups was very 
different, and so will likely have differed in motivations, 
contexts for opportunity to use the app and incentivisa-
tions.50 While these aspects were not considered in the 
other studies, our use of qualitative research has enabled 
us to explore these in more depth. Our findings suggest 
these are important considerations in any study of app 
use, and therefore this study makes a contribution to the 
field. For example, some of the groups in other studies 
may have differed from ours in the likelihood of using 
mHealth apps in the first place and familiarity with tech-
nology. Inpatients may have more time to use the app and 
more support, and may also have had specific barriers to 
the use of apps, such as related to setting and to illness.
Patients in the qualitative part of our study tended 
not to use apps on a regular basis (or at least apps other 
than simple games), and in terms of our themes, also 
represented in the COM- B model, may be said to have 
few capabilities in technology use. They therefore do not 
represent the typical users of the Headspace app in a 
commercial setting. Accessing the app regularly requires 
energy, time and effort, but patients with CPP often suffer 
from fatigue and anxiety as comorbidities, perhaps while 
having to juggle family life and work. Therefore, this may 
be seen as a challenging clinical population in which to 
trial an app. Further Headspace trials in outpatients with 
diabetes (NCT03274362) and pain (NCT03495726) are 
under way.
Our study has also shown that clear consideration 
of unexpected benefits should be included in future 
studies, and these can be informed by our finding that 
benefits for patients may be more diffuse than antici-
pated (eg, app relieving stress rather than pain). Such 
benefits were found in the active control as well as the 
intervention arm, and so it may be that they represent 
a placebo effect, although the effect could equally be 
real. Our data also suggest that staff benefits may be 
less than anticipated, as participants sometimes needed 
a lot of support and scaffolding in technology use at 
least initially.
Young age, comorbid anxiety and low educational 
attainment are predictors for dropping out of web- 
based interventions, according to studies in the field of 
depression.51 52 This may be true despite regular phone 
support,52 although our participants all considered 
active motivational support from staff or app support 
groups would have improved app use. Our intervention 
arm participants were particularly likely to be young 
and with low educational attainment.
Our data suggest that it is important to involve real- 
world end users in the agile design or development 
or modification of apps, in close collaboration with 
researchers and commercial app developers.7 Although 
the evaluation of existing apps has been recommended 
as a cost- effective and rapid process,24 our findings 
suggest that in actual clinical practice these may be 
problematic.
Strengths and weaknesses of the study and in relation to 
other studies
One strength of this study is that it provides much- needed 
evidence in the field of evaluating existing health apps in 
a clinical population6 8 24 and recording user experience. 
This provides us with lessons to be learnt.
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Researchers conducting the interviews and focus 
groups included a senior mixed methods medical 
sociology researcher, a recruiting nurse, a represen-
tative from the Pelvic Pain Support Network and an 
experienced health psychologist. Findings were similar 
across the data, therefore the different backgrounds of 
the researchers do not appear to have influenced the 
findings. The main analysis was undertaken by a medical 
sociologist and so concordance with the COM- B model 
is not due to background discipline bias.
We were able to successfully recruit participants, and 
we obtained valuable information from patients with CPP 
who were recruited from a deprived urban area in the UK 
and who were typical local clinical patients.
However, we report a marked discrepancy between the 
attitudes of the prestudy PPI group of volunteer patients 
from the local area, who actively put themselves forward 
for a 7- day trial of the app, and the participants asked 
to take part when they attended clinics. The opinions 
of prestudy PPI volunteers meeting in their private time 
may not be representative of the opinions of patients 
recruited at a routine clinic appointment. Women in 
the PPI group were used to using apps, which had led 
them to be interested in the study in the first place. 
Whereas women in the PPI group had all trialled the 
app at home and work without support from us, many 
patients from clinics were unable to use their phone 
beyond calls, texts and photos. Moreover, most of the 
women we interviewed used the intervention app. We 
can only speculate as to why this is so, but it does mean 
that concordances and divergences across the interven-
tion and active control arm do need to be treated with 
circumspection.
To our knowledge the present observation on failure 
of the PPI work to translate into practice in a trial has 
not been formally reported before, and is lacking from 
a recent comprehensive systematic review.53 PPI is a stip-
ulated requirement when applying for some funding, 
and the present research findings should be taken into 
account when drafting guidelines for future PPI. PPI 
groups are able to provide significant help and advice 
in any study, but our findings show the value of adding 
agile codevelopment as a requirement for app interven-
tion development as likely to provide a more effective 
intervention than one informed by PPI alone. More-
over, there is a difference between app use for active 
clinical management (as with our study participants) 
and consideration of the potential use of app for this 
(as with our PPI group).
Implications for clinicians and policymakers
Given the patchy use of the app and the way that some 
participants did not manage to unlock its full function-
ality, and an indication of diffusion of benefit, more 
work is needed to see whether the app reduces pain per 
se. This study is a good example of the need to move 
away from ‘one size fits all’ behavioural interventions. 
Future studies should do more work on implementation 
before doing an effectiveness trial. This will enable 
researchers to be more nuanced about saying who the 
app is effective for, if at all.
Strategies to involve busy, less motivated and less 
technologically experienced individuals in PPI and 
lay app design groups need to be further developed. 
These groups should include considerable scaffolding, 
which we have shown extends to study involvement by 
patients. More care is also needed to obtain PPI input 
that is representative of the target group, taking into 
account their capabilities, opportunities and motiva-
tional aspects. It may be useful to give the PPI group a 
small condition management task that emulates what 
trial participants will be required to do. Moreover, we 
can confirm a recent review suggesting that health 
apps should be codesigned with users,7 rather than 
presenting them with a pre- existing app. These implica-
tions in our study are also generalisable to other studies 
on technology.
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